The Centre for Cellular and Molecular Biology (CCMB) is working on the development of cost-effective and accurate diagnostic kits to deal with the threat of coronavirus spread and is also planning to culture COVID-19 virus.
CCMB director R K Mishra said that they were helping incubating companies.
"They have come out with ideas and we are supporting them. We are testing and validating the diagnostic kits proposed by them. We may come up with some good kits and it may take at least 2-3 weeks if everything goes well. Quality and accuracy of the kits are the most important things. If the kits give 100 per cent results, then only they will be approved," he said.
According to a release of the Ministry of Science and Technology, the CCMB is also keeping in mind the cost.
"Our estimate is that the test cost should be less than Rs 1,000. We are also thinking of kits which are as cheap as Rs 400-500 but at present, we cannot assure that as it is a different route and all this needs more standardisation," said Mishra.
He said the CCMB is also planning to culture the COVID-19 virus and the institution has facilities for this. Mishra said they have got approvals from the government but are yet to receive sample and kits to initiate the culture.
He said there are five government-designated testing centres in Telangana and CCMB has trained 25 people so that they can go and do the testing at these centres.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
